HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$1.34
Day range
$1.06 - $1.35
Year range
$0.42 - $138.00
Market cap
7.28M USD
Avg Volume
2.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.29M | -32.89% |
Net income | -3.33M | 30.94% |
Net profit margin | — | — |
Earnings per share | -0.65 | — |
EBITDA | -3.26M | 33.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.91M | 201.07% |
Total assets | 7.29M | 30.41% |
Total liabilities | 2.71M | -53.56% |
Total equity | 4.58M | — |
Shares outstanding | 6.62M | — |
Price to book | 1.70 | — |
Return on assets | -131.98% | — |
Return on capital | -234.42% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.33M | 30.94% |
Cash from operations | -3.94M | 12.77% |
Cash from investing | -3.84K | 70.25% |
Cash from financing | 6.09M | 415.56% |
Net change in cash | 2.15M | 164.14% |
Free cash flow | -2.75M | -13.63% |
About
Founded
2016
Headquarters
Website
Employees
10